Bayer, J&J settle U.S. Xarelto litigation for $775 million

FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay/File Photo - Copyright WOLFGANG RATTAY(Reuters)

By Reuters

Published on 25/03/2019 - 16:04•Updated 26/04/2024 - 00:11

Comments

(Reuters) - Bayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million (588 million pounds), court documents on Monday showed.

The amount will be shared equally between the two companies that jointly developed the drug. Bayer and J&J do not admit liability under the agreement.